Structures published

Total: 34

Allyl 6-amino-5-cyano-2-methyl-4-phenyl-4H-pyran-3-carboxylate

C₁₇H₁₆N₂O₃

G. Anantha Krishnan C. Udhaya Kumar T. Mohandas M. Velayutham Pillai P. Sakthivel

IUCrData (2019) 4, 1 0-0

a=8.2151(5)Å b=9.2850(5)Å c=11.6086(7)Å

α=108.184(4)° β=103.004(4)° γ=105.089(2)°

Ethyl 2,2-dimethyl-4-oxo-6-phenyl-3,4-dihydro-2H-pyran-5-carboxylate

C₁₆H₁₈O₄

Sharmila, N.Sundar, T. V.Sakthivel, P.Venkatesan, P.

IUCrData (2016) 1, 12 x161924

a=10.4566(2)Å b=5.98210(10)Å c=12.2040(3)Å

α=90° β=97.4600(10)° γ=90°

Ethyl 2,2-dimethyl-4-oxo-6-phenyl-2,3-dihydro-4H-pyran-5-carboxylate

C₁₆H₁₇ClO₄

Sharmila, N.Sundar, T. V.Sakthivel, P.Venkatesan, P.

IUCrData (2017) 2, 1 x170034

a=10.4412(3)Å b=7.6959(2)Å c=20.2651(5)Å

α=90° β=102.311(2)° γ=90°

C₁₄H₁₆O₄S

Ilangovan, Andivelu Sakthivel, Palaniappan

RSC Adv. (2014)

a=10.4001(2)Å b=20.6610(6)Å c=13.5979(4)Å

α=90° β=91.972(2)° γ=90°

Isobutyl 4-(2-chlorophenyl)-5-cyano-6-{(E)-[(dimethylamino)methylidene]amino}-2-methyl-4H-pyran-3-carboxylate

C₂₁H₂₄ClN₃O₃

Mohandas, T.Kumar, C. Udhaya Devi, S. Aruna Prakasam, B. Arul Sakthivel, P.Vidhyasagar, T.

Acta Crystallographica Section E (2015) 71, 2 o101-o102

a=15.6836(16)Å b=15.2523(13)Å c=9.3283(8)Å

α=90.00° β=105.016(2)° γ=90.00°

(E)-4-(Acetoxyimino)-N-allyl-3-isopropyl-2,6-diphenylpiperidine-1-carbothioamide

C₂₆H₃₂N₃O₂S

Mohandas, T.Krishnan, K. Gokula Balamurugan, S.Harrison, William T. A.Thanikachalam, V.Sakthivel, P.

Acta Crystallographica Section E (2015) 71, 8 o542-o543

a=12.0434(6)Å b=14.0479(7)Å c=15.2740(7)Å

α=82.161(2)° β=72.463(2)° γ=80.094(2)°

1-(4-Methoxyphenyl)-2-[4-(trifluromethyl)phenyl]-1H-phenanthro[9,10-d]imidazole

C₂₉H₁₉F₃N₂O

Mohandas, T.Sathishkumar, R.Jayabharathi, J.Pasupathi, A.Sakthivel, P.

Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 8 o1293-4

a=11.7063(9)Å b=20.2301(16)Å c=9.5419(8)Å

α=90.00° β=99.725(2)° γ=90.00°

2-(4-Fluorophenyl)-1-(4-methoxyphenyl)-1H-phenanthro[9,10-d]imidazole

C₂₈H₁₉FN₂O

Mohandas, T.Sathishkumar, R.Sakthivel, P.Jayabharathi, J.

Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 3 o368

a=9.6430(3)Å b=9.8980(3)Å c=12.3070(4)Å

α=77.4320(10)° β=71.6210(10)° γ=73.1580(10)°

1-(3,5-Dimethylphenyl)-2-(4-fluorophenyl)-1H-phenanthro[9,10-d]imidazole

C₂₉H₂₁FN₂

Sathishkumar, R.Mohandas, T.Sakthivel, P.Jayabharathi, J.

Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 3 o367

a=8.5680(2)Å b=10.6070(3)Å c=23.6900(6)Å

α=90° β=93.8990(10)° γ=90°

Glycine--D-tartaric acid (1/1)

C₂H₅NO_2,C₄H₆O₆

Mohandas, T.Inbaseelan, C. Ranjith Dev Saravanan, S.Sakthivel, P.

Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o236

a=4.8387(2)Å b=9.2913(4)Å c=20.0273(8)Å

α=90.00° β=90.1710(10)° γ=90.00°

1-Phenyl-2-[4-(trifluoromethyl)phenyl]-1H-benzimidazole

C₂₀H₁₃F₃N₂

Jayamoorthy, K.Mohandas, T.Sakthivel, P.Jayabharathi, J.

Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o244

a=8.7179(4)Å b=9.6796(5)Å c=11.3612(6)Å

α=67.654(2)° β=68.123(2)° γ=85.013(2)°

2-(4-Methoxyphenyl)-1-phenyl-1H-benzimidazole

C₂₀H₁₆N₂O

Mohandas, T.Jayamoorthy, K.Jayabharathi, J.Sakthivel, P.

Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o269-70

a=12.3220(3)Å b=7.3030(2)Å c=18.2450(3)Å

α=90° β=108.9090(10)° γ=90°

Methyl ({[(4E)-1,3-dimethyl-2,6-diphenylpiperidin-4-ylidene]amino}oxy)acetate

C₂₂H₂₆N₂O₃

Mohandas, T.Pillai, M. Velayutham Vidhyasagar, T.Pasupathy, A.Sakthivel, P.

Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 5 o513

a=8.1662(9)Å b=15.0229(16)Å c=16.2889(19)Å

α=90° β=93.903(6)° γ=90°

Indole

C₂₁H₁₅NO₃S₂

P. Sakthivel.K. SethuSankar P. Jaishankar P. S. Joseph

Acta Crystallographica Section E (2006) 62, 4 o1199-o1201

a=10.003(4)Å b=16.001(6)Å c=11.750(5)Å

α=90.00° β=97.80(3)° γ=90.00°

3-Bromo-2-bromomethyl-1-phenylsulfonyl-1H-indole

C₁₅H₁₁Br₂NO₂S

P. Sakthivel K. Sethusankar P. Jai Sankar P. S. Joseph

Acta Crystallographica Section E (2007) 63, 3 o1521-o1522

a=7.57300(10)Å b=9.52200(10)Å c=10.9660(2)Å

α=102.048(2)° β=90.7630(10)° γ=101.462(2)°

Morpholine

C₉H₁₄N₂O₃

P. Sakthivel P. S. Joseph A. Sebastin M. Yosuva Suvaikin M. Ramesh

Acta Crystallographica Section E (2007) 63, 10 o4143-o4143

a=6.1368(2)Å b=7.8038(3)Å c=20.9032(8)Å

α=90° β=98.202(2)° γ=90°

Morpholine

C₁₃H₁₄N₂O₃

P. Sakthivel P. S. Joseph A. Sebastiyan M. Ramesh M. Yosuva Suvaikin

Acta Crystallographica Section E (2007) 63, 11 o4284-o4284

a=9.3891(6)Å b=5.4617(3)Å c=23.5796(16)Å

α=90° β=92.209(2)° γ=90°

Pyrrolidine

C₁₃H₁₄N₂O₂

P. Sakthivel P. S. Joseph A. Sebastiyan M. Yosuva Suvaikin M. Ramesh

Acta Crystallographica Section E (2007) 63, 11 o4388-o4388

a=9.0609(3)Å b=10.0777(3)Å c=13.0192(3)Å

α=90° β=90° γ=90°

Thiadiazole

C₁₇H₂₂N₄O₃S

P. Sakthivel P. S. Joseph P. Thomas Muthiah K. Sethusankar S. Thennarasu

Acta Crystallographica Section E (2008) 64, 1 o216-o216

a=18.3623(9)Å b=14.1565(7)Å c=14.1386(7)Å

α=90° β=90° γ=90°

Indole

C₁₆H₁₂N₂O₂S

P. Sakthivel K. Sethusankar P. Jai shankar P. S. Joseph

Acta Crystallographica Section E (2007) 63, 4 o1947-o1948

a=9.73440(10)Å b=12.32950(10)Å c=13.3352(2)Å

α=102.629(2)° β=97.8490(10)° γ=112.325(2)°

R-2,c-6-Bis(4-methoxyphenyl)-c-3,t-3-dimethyl-1-nitrosopiperidin-4-one

C₂₁H₂₄N₂O₄

Kavitha, T.Ponnuswamy, S.Sakthivel, P.Karthik, K.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 6 o1420

a=7.2540(3)Å b=15.0469(6)Å c=17.0741(7)Å

α=90.00° β=90.00° γ=90.00°

5-Chloroacetyl-4-methyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one

C₁₂H₁₃ClN₂O₂

Ravichandran, K.Sakthivel, P.Ponnuswamy, S.Ramesh, P.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 10 o2361

a=16.7656(4)Å b=8.8171(2)Å c=17.0125(4)Å

α=90.00° β=105.8030(10)° γ=90.00°

4-Methyl-2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-5-carbaldehyde

C₁₁H₁₂N₂O₂

Ravichandran, K.Sakthivel, P.Ponnuswamy, S.Ramesh, P.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 10 o2362

a=5.32840(10)Å b=12.9387(4)Å c=14.6227(5)Å

α=90.00° β=97.968(2)° γ=90.00°

N~5~-Dichloroacetyltetrahydro-4-methyl-1,5-benzodiazepin-2-one hemihydrate

2(C₁₂H₁₂Cl₂N₂O₂)_,H₂O

Ravichandran, K.Sakthivel, P.Ponnuswamy, S.Shalini, M.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 10 o2551-o2552

a=8.5470(3)Å b=18.0837(6)Å c=8.8697(3)Å

α=90.00° β=95.405(2)° γ=90.00°

1-Formyl-r-2,c-6-bis(4-methoxyphenyl)-c-3,t-3-dimethylpiperidin-4-one

C₂₂H₂₅NO₄

Kavitha, T.Ponnuswamy, S.Sakthivel, P.Karthik, K.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 4 o856

a=11.7274(3)Å b=18.8556(4)Å c=9.7178(3)Å

α=90.00° β=113.5070(10)° γ=90.00°

T-3-Ethyl-r-2,c-6-bis(4-methoxyphenyl)-1-nitrosopiperidin-4-one

C₂₁H₂₄N₂O₄

Kavitha, T.Thenmozhi, M.Ponnuswamy, S.Sakthivel, P.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 8 o1765

a=7.2742(4)Å b=15.8459(7)Å c=16.4800(7)Å

α=90.00° β=90.00° γ=90.00°

1-Formyl-t-3,t-5-dimethyl-r-2,c-6-diphenylpiperidin-4-one

C₂₀H₂₁NO₂

Ravichandran, K.Ramesh, P.Sakthivel, P.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 6 o1505

a=7.4303(4)Å b=15.3567(6)Å c=29.6732(13)Å

α=90.00° β=90.00° γ=90.00°

1-Chloroacetyl-r-2,c-6-bis(4-methoxyphenyl)-t-3-methylpiperidin-4-one

C₂₂H₂₄ClNO₄

Ravichandran, K.Ramesh, P.Sakthivel, P.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 11 o2883

a=8.9147(8)Å b=11.9648(10)Å c=19.1365(16)Å

α=99.729(5)° β=93.665(5)° γ=90.112(6)°

1-Formyl-r-2,c-6-bis(4-methoxyphenyl)- t-3,t-5-dimethylpiperidin-4-one

C₂₂H₂₅NO₄

Kavitha, T.Sakthivel, P.Ponnuswamy, S.Ilango, S. S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2009) 65, 11 o2818

a=11.0954(4)Å b=14.5407(3)Å c=12.7050(4)Å

α=90.00° β=110.9770(10)° γ=90.00°

Piperidin-4-one

C₂₁H₂₃NO₄

Gayathri, P.Sakthivel, P.Ponnuswamy, S.Thiruvalluvar, A.Butcher, R. J.

Acta Crystallographica Section E (2009) 65, 11 o2813

a=11.5409(4)Å b=12.4972(5)Å c=14.7816(6)Å

α=67.878(4)° β=74.719(3)° γ=67.123(4)°

1-Dichloroacetyl-r-2,c-6-bis(4-methoxyphenyl)-t-3-methylpiperidin-4-one

C₂₂H₂₃Cl₂NO₄

Ravichandran, K.Ramesh, P.Sakthivel, P.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2010) 66, 2 o262

a=19.3021(16)Å b=10.5886(9)Å c=10.3241(10)Å

α=90.00° β=91.445(5)° γ=90.00°

(E)-3-Methyl-2,6-diphenylpiperidin-4-one O-(3-methylbenzoyl)oxime

C₂₆H₂₆N₂O₂

Kathiravan, V.Krishnan, K. Gokula Mohandas, T.Thanikachalam, V.Sakthivel, P.

Acta Crystallographica Section E (2014) 70, 8 o883

a=10.6265(6)Å b=12.7146(7)Å c=16.4031(8)Å

α=90.00° β=99.524(2)° γ=90.00°

1-Formyl-c-3,t-3-dimethyl-r-2,c-6-diphenylpiperidin-4-one

C₂₀H₂₁NO₂

Ravichandran, K.Sakthivel, P.Ramesh, P.Ponnuswamy, S.Ponnuswamy, M. N.

Acta Crystallographica Section E (2012) 68, 3 o870

a=10.6604(6)Å b=15.7278(7)Å c=10.8066(5)Å

α=90.00° β=110.120(2)° γ=90.00°

2-(4-(trifluoromethyl)phenyl)-1H-phenanthro[9,10-d]imidazole

C₂₉H₁₉F₃N₂

Mohandas, T.Sathishkumar, R.Jayabharathi, J.Pasupathy, A.Sakthivel, P.

Acta Crystallographica Section E (2013) 69, 5 o710

a=8.113(3)Å b=11.733(5)Å c=12.713(2)Å

α=76.3970(10)° β=73.490(2)° γ=86.185(5)°

Structures by: Sakthivel P.

Total: 34

Allyl 6-amino-5-cyano-2-methyl-4-phenyl-4<i>H</i>-pyran-3-carboxylate

Ethyl 2,2-dimethyl-4-oxo-6-phenyl-3,4-dihydro-2<i>H</i>-pyran-5-carboxylate

Ethyl 2,2-dimethyl-4-oxo-6-phenyl-2,3-dihydro-4H-pyran-5-carboxylate

C₁₄H₁₆O₄S

Isobutyl 4-(2-chlorophenyl)-5-cyano-6-{(<i>E</i>)-[(dimethylamino)methylidene]amino}-2-methyl-4<i>H</i>-pyran-3-carboxylate

(<i>E</i>)-4-(Acetoxyimino)-<i>N</i>-allyl-3-isopropyl-2,6-diphenylpiperidine-1-carbothioamide

1-(4-Methoxyphenyl)-2-[4-(trifluromethyl)phenyl]-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole

2-(4-Fluorophenyl)-1-(4-methoxyphenyl)-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole

1-(3,5-Dimethylphenyl)-2-(4-fluorophenyl)-1<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole

Glycine--<i>D</i>-tartaric acid (1/1)

1-Phenyl-2-[4-(trifluoromethyl)phenyl]-1<i>H</i>-benzimidazole

2-(4-Methoxyphenyl)-1-phenyl-1<i>H</i>-benzimidazole

Methyl ({[(4<i>E</i>)-1,3-dimethyl-2,6-diphenylpiperidin-4-ylidene]amino}oxy)acetate

Indole

3-Bromo-2-bromomethyl-1-phenylsulfonyl-1H-indole

Morpholine

Morpholine

Pyrrolidine

Thiadiazole

Indole

R-2,c-6-Bis(4-methoxyphenyl)-c-3,t-3-dimethyl-1-nitrosopiperidin-4-one

5-Chloroacetyl-4-methyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one

4-Methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepine-5-carbaldehyde

N~5~-Dichloroacetyltetrahydro-4-methyl-1,5-benzodiazepin-2-one hemihydrate

1-Formyl-r-2,c-6-bis(4-methoxyphenyl)-c-3,t-3-dimethylpiperidin-4-one

T-3-Ethyl-r-2,c-6-bis(4-methoxyphenyl)-1-nitrosopiperidin-4-one

1-Formyl-<i>t</i>-3,<i>t</i>-5-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one

1-Chloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one

1-Formyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)- <i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one

Piperidin-4-one

1-Dichloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one

(<i>E</i>)-3-Methyl-2,6-diphenylpiperidin-4-one <i>O</i>-(3-methylbenzoyl)oxime

1-Formyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one

2-(4-(trifluoromethyl)phenyl)-1H-phenanthro[9,10-d]imidazole